New device may shorten labor in late pregnancy termination
NCT ID NCT03194230
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times
Summary
This study looked at whether placing a cervical dilator (Dilapan-S) before medication can shorten labor in second-trimester medical termination of pregnancy. 355 women participated. The main goal was to see if more women delivered within 12 hours with the dilator. Results could help make the procedure faster and more comfortable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TERMINATION OF PREGNANCY (TOP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Maternité Port Royal
Paris, 75014, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hygroscopic cervical dilator (Dilapan-S)
What this could lead to
If effective, using cervical dilators could make second-trimester termination of pregnancy faster and more predictable.
What could go wrong
This is a completed study, but the intervention is a device, not a drug, and results may not apply to all patients. Risks include infection or failed induction.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.